# Colchicine to Reduce Coronary Artery Inflammation in People With HIV

> **NCT07704164** · PHASE2 · RECRUITING · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 90 (estimated)

## Conditions studied

- HIV Infection
- Cardiovascular Diseases (CVD)

## Interventions

- **DRUG:** Colchicine 0.5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07704164
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12
- **Final completion:** 2029-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704164, "Colchicine to Reduce Coronary Artery Inflammation in People With HIV". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*